These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 25855381

  • 1. Development of lung adenocarcinomas with exclusive dependence on oncogene fusions.
    Saito M, Shimada Y, Shiraishi K, Sakamoto H, Tsuta K, Totsuka H, Chiku S, Ichikawa H, Kato M, Watanabe S, Yoshida T, Yokota J, Kohno T.
    Cancer Res; 2015 Jun 01; 75(11):2264-71. PubMed ID: 25855381
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Gene status and clinicopathologic characteristics of lung adenocarcinomas with mediastinal lymph node metastasis.
    Zhang S, Yan B, Zheng J, Zhao J, Zhou J.
    Oncotarget; 2016 Sep 27; 7(39):63758-63766. PubMed ID: 27563816
    [Abstract] [Full Text] [Related]

  • 4. Decoding Tumor Phenotypes for ALK, ROS1, and RET Fusions in Lung Adenocarcinoma Using a Radiomics Approach.
    Yoon HJ, Sohn I, Cho JH, Lee HY, Kim JH, Choi YL, Kim H, Lee G, Lee KS, Kim J.
    Medicine (Baltimore); 2015 Oct 27; 94(41):e1753. PubMed ID: 26469915
    [Abstract] [Full Text] [Related]

  • 5. Unique prevalence of oncogenic genetic alterations in young patients with lung adenocarcinoma.
    Tanaka K, Hida T, Oya Y, Yoshida T, Shimizu J, Mizuno T, Kuroda H, Sakakura N, Yoshimura K, Horio Y, Sakao Y, Yatabe Y.
    Cancer; 2017 May 15; 123(10):1731-1740. PubMed ID: 28177518
    [Abstract] [Full Text] [Related]

  • 6. RET, ROS1 and ALK fusions in lung cancer.
    Takeuchi K, Soda M, Togashi Y, Suzuki R, Sakata S, Hatano S, Asaka R, Hamanaka W, Ninomiya H, Uehara H, Lim Choi Y, Satoh Y, Okumura S, Nakagawa K, Mano H, Ishikawa Y.
    Nat Med; 2012 Feb 12; 18(3):378-81. PubMed ID: 22327623
    [Abstract] [Full Text] [Related]

  • 7. Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions.
    Suehara Y, Arcila M, Wang L, Hasanovic A, Ang D, Ito T, Kimura Y, Drilon A, Guha U, Rusch V, Kris MG, Zakowski MF, Rizvi N, Khanin R, Ladanyi M.
    Clin Cancer Res; 2012 Dec 15; 18(24):6599-608. PubMed ID: 23052255
    [Abstract] [Full Text] [Related]

  • 8. [Detection of ALK, ROS1 and RET fusion genes in non-small cell lung cancer patients and its clinicopathologic correlation].
    Zhong S, Zhang H, Bai D, Gao D, Zheng J, Ding Y.
    Zhonghua Bing Li Xue Za Zhi; 2015 Sep 15; 44(9):639-43. PubMed ID: 26705279
    [Abstract] [Full Text] [Related]

  • 9. A single-tube multiplexed assay for detecting ALK, ROS1, and RET fusions in lung cancer.
    Lira ME, Choi YL, Lim SM, Deng S, Huang D, Ozeck M, Han J, Jeong JY, Shim HS, Cho BC, Kim J, Ahn MJ, Mao M.
    J Mol Diagn; 2014 Mar 15; 16(2):229-43. PubMed ID: 24418728
    [Abstract] [Full Text] [Related]

  • 10. KIF5B-RET fusions in lung adenocarcinoma.
    Kohno T, Ichikawa H, Totoki Y, Yasuda K, Hiramoto M, Nammo T, Sakamoto H, Tsuta K, Furuta K, Shimada Y, Iwakawa R, Ogiwara H, Oike T, Enari M, Schetter AJ, Okayama H, Haugen A, Skaug V, Chiku S, Yamanaka I, Arai Y, Watanabe S, Sekine I, Ogawa S, Harris CC, Tsuda H, Yoshida T, Yokota J, Shibata T.
    Nat Med; 2012 Feb 12; 18(3):375-7. PubMed ID: 22327624
    [Abstract] [Full Text] [Related]

  • 11. Intratumoral Heterogeneity of ALK-Rearranged and ALK/EGFR Coaltered Lung Adenocarcinoma.
    Cai W, Lin D, Wu C, Li X, Zhao C, Zheng L, Chuai S, Fei K, Zhou C, Hirsch FR.
    J Clin Oncol; 2015 Nov 10; 33(32):3701-9. PubMed ID: 26416997
    [Abstract] [Full Text] [Related]

  • 12. From genotype to phenotype: Are there imaging characteristics associated with lung adenocarcinomas harboring RET and ROS1 rearrangements?
    Plodkowski AJ, Drilon A, Halpenny DF, O'Driscoll D, Blair D, Litvak AM, Zheng J, Moskowitz CS, Ginsberg MS.
    Lung Cancer; 2015 Nov 10; 90(2):321-5. PubMed ID: 26424208
    [Abstract] [Full Text] [Related]

  • 13. Identification of ALK, ROS1, and RET Fusions by a Multiplexed mRNA-Based Assay in Formalin-Fixed, Paraffin-Embedded Samples from Advanced Non-Small-Cell Lung Cancer Patients.
    Reguart N, Teixidó C, Giménez-Capitán A, Paré L, Galván P, Viteri S, Rodríguez S, Peg V, Aldeguer E, Viñolas N, Remon J, Karachaliou N, Conde E, Lopez-Rios F, Nadal E, Merkelbach-Bruse S, Büttner R, Rosell R, Molina-Vila MA, Prat A.
    Clin Chem; 2017 Mar 10; 63(3):751-760. PubMed ID: 28073897
    [Abstract] [Full Text] [Related]

  • 14. Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion.
    Tsai TH, Wu SG, Hsieh MS, Yu CJ, Yang JC, Shih JY.
    Lung Cancer; 2015 May 10; 88(2):208-14. PubMed ID: 25773866
    [Abstract] [Full Text] [Related]

  • 15. Epidermal Growth Factor Receptor (EGFR) Mutations and Anaplastic Lymphoma Kinase/Oncogene or C-Ros Oncogene 1 (ALK/ROS1) Fusions Inflict Non-Small Cell Lung Cancer (NSCLC) Female Patients Older Than 60 Years of Age.
    Ke L, Xu M, Jiang X, Sun X.
    Med Sci Monit; 2018 Dec 23; 24():9364-9369. PubMed ID: 30580372
    [Abstract] [Full Text] [Related]

  • 16. ALK, ROS1 and RET rearrangements in lung squamous cell carcinoma are very rare.
    Zhao W, Choi YL, Song JY, Zhu Y, Xu Q, Zhang F, Jiang L, Cheng J, Zheng G, Mao M.
    Lung Cancer; 2016 Apr 23; 94():22-7. PubMed ID: 26973202
    [Abstract] [Full Text] [Related]

  • 17. Comprehensive analysis of RET and ROS1 rearrangement in lung adenocarcinoma.
    Lee SE, Lee B, Hong M, Song JY, Jung K, Lira ME, Mao M, Han J, Kim J, Choi YL.
    Mod Pathol; 2015 Apr 23; 28(4):468-79. PubMed ID: 25234288
    [Abstract] [Full Text] [Related]

  • 18. [Clinical features of 54 cases of lung adenocarcinomas with c-ROS oncogene 1 fusion].
    Cao H, Zheng J, Zhao J, Guo XJ, Zhou JY, Ding W, Zhou JY.
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Feb 12; 43(2):120-125. PubMed ID: 32062881
    [Abstract] [Full Text] [Related]

  • 19. [Correlation of clinicopathologic features and driver gene mutation in non-small cell lung cancer].
    Chen LF, Chen XY, Yu XB.
    Zhonghua Bing Li Xue Za Zhi; 2016 Apr 08; 45(4):221-5. PubMed ID: 27033383
    [Abstract] [Full Text] [Related]

  • 20. Expression of C-terminal ALK, RET, or ROS1 in lung cancer cells with or without fusion.
    Furugaki K, Mochizuki M, Kohno M, Shu S, Harada N, Yoshimura Y.
    BMC Cancer; 2019 Apr 03; 19(1):301. PubMed ID: 30943926
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.